Page last updated: 2024-08-23

daunorubicin and warfarin

daunorubicin has been researched along with warfarin in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (25.00)18.2507
2000's2 (25.00)29.6817
2010's4 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bettaïeb, A; Jaffrézou, JP; Laurent, G; Levade, T; Mansat, V1
Belloc, F; Bernard, P; Boisseau, MR; Chabrol, J; Dachary-Prigent, J; Dumain, P; Durrieu, F; Lacombe, F; Lacoste, L; Morjani, H; Reiffers, J1
Bruno, AP; d'Orgeix, AT; Laurent, G; Lautier, D; Quillet-Mary, A1
Barbier, P; Bourgarel-Rey, V; Boutonnat, J; Combes, S; Douillard, S; Fedorov, AY; Finet, JP; McLeer-Florin, A; Peyrot, V; Pierson, JT1
Chae, SW; Kim, HJ; Kim, NH; Lee, HJ; Lee, K; Rhie, S; Xia, Y1

Reviews

1 review(s) available for daunorubicin and warfarin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

7 other study(ies) available for daunorubicin and warfarin

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Serine protease inhibitors block neutral sphingomyelinase activation, ceramide generation, and apoptosis triggered by daunorubicin.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 1997, Volume: 11, Issue:8

    Topics: Antibiotics, Antineoplastic; Antipain; Apoptosis; Ceramides; Coumarins; Daunorubicin; DNA Fragmentation; Dose-Response Relationship, Drug; Enzyme Activation; HL-60 Cells; Humans; Hydrolysis; Isocoumarins; Leupeptins; NF-kappa B; Pepstatins; Protease Inhibitors; Serine Proteinase Inhibitors; Signal Transduction; Sphingomyelin Phosphodiesterase; Sphingomyelins; Tosylphenylalanyl Chloromethyl Ketone; Tumor Cells, Cultured

1997
Caspase activation is an early event in anthracycline-induced apoptosis and allows detection of apoptotic cells before they are ingested by phagocytes.
    Experimental cell research, 1998, May-01, Volume: 240, Issue:2

    Topics: Animals; Annexin A5; Antibiotics, Antineoplastic; Apoptosis; Caspase 3; Caspases; CD36 Antigens; CHO Cells; Coumarins; Cricetinae; Cysteine Endopeptidases; Daunorubicin; Enzyme Activation; Enzyme Inhibitors; Fluorescent Dyes; HL-60 Cells; Humans; Oligopeptides; Phagocytes; Phagocytosis; Sphingosine; Substrate Specificity; Tumor Cells, Cultured

1998
Acute myeloblastic leukemic cells acquire cellular cytotoxicity under genotoxic stress: implication of granzyme B and perforin.
    Blood, 2000, Sep-01, Volume: 96, Issue:5

    Topics: Antigens, CD34; Antineoplastic Agents; Cell Survival; Coumarins; Cytarabine; Cytotoxicity Tests, Immunologic; Daunorubicin; DNA, Antisense; Edetic Acid; Etoposide; Flow Cytometry; Granzymes; HeLa Cells; Humans; Isocoumarins; Jurkat Cells; K562 Cells; Leukemia, Myeloid, Acute; Magnesium Chloride; Membrane Glycoproteins; Perforin; Pore Forming Cytotoxic Proteins; Serine Endopeptidases; Tumor Cells, Cultured; U937 Cells

2000
Synthesis and biological evaluation of 4-arylcoumarin analogues of combretastatins. Part 2.
    Journal of medicinal chemistry, 2011, May-12, Volume: 54, Issue:9

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Division; Cell Line; Cell Line, Tumor; Coumarins; Crystallography, X-Ray; Daunorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; G2 Phase; Humans; Mitoxantrone; Models, Molecular; Neoplasm Proteins; Stilbenes; Structure-Activity Relationship; Tubulin; Tubulin Modulators

2011
Effect of coumarin derivative-mediated inhibition of P-glycoprotein on oral bioavailability and therapeutic efficacy of paclitaxel.
    European journal of pharmacology, 2014, Jan-15, Volume: 723

    Topics: Administration, Oral; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Cell Line, Tumor; Cell Survival; Coumarins; Daunorubicin; Humans; Male; Mice; Mice, Nude; Neoplasms; Paclitaxel; Rats; Rats, Sprague-Dawley; Treatment Outcome; Tumor Burden; Xenograft Model Antitumor Assays

2014